Company profile

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

b1_wh_2m.jpg
b1_wh_1v.jpg
b1_wh_3v.jpg
M

Corporate Mission

Empowering Doctors, Enhance Life
To shorten patient’s visit time by 1 hour with BioGerm products
and services

Corporate Mission

V

Corporate Vision

To be a world-class expert in pathogen diagnosis

Corporate Vision

V

Values

Customer-first, innovation-driven, grateful and ready to help

Values

2022

AprilNovel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) was granted the NMPA Registration Certificate
Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) was granted CE Certification

May21 varieties of viral nucleic acid detection kits were granted CE Certification
Monkeypox Virus Nucleic Acid Detection Kit was granted CE Certification

2021

JanuaryBiogerm was awarded the 2020 Special Contribution Award of Shanghai Industrial Comprehensive Development Zone

JuneBiogerm came out among the best in the proportion of laboratories in the national inter-laboratory quality appraise

AugustBiogerm Six Respiratory Pathogens Nucleic Acid Detection Kit launched in the market
Biogerm Norovirus Nucleic Acid Detection Kit was approved for marketing

SeptemberThe Isothermal Nucleic Acid Amplifier was granted the NMPA Registration Certificate
Biogerm was awarded the first prize of Shanghai Science and Technology Progress Award

2020

JanuaryThe Coronavirus Nucleic Acid Detection Kit passed the validation of CDC, was granted the NMPA Registration Certificate, and was included in the government emergency capacity requisition list of Shanghai Municipal Working Committee of Economy and Informatization

MarchThe review by Brazil National Health Surveillance Agency was completed

JuneThe review by Malaysia National Pharmaceutical Control Bureau was completed

JulyThe review by Singapore Health Sciences Authority was completed
The review by Thailand Food and Drug Administration was completed
The review by Philippine Food and Drug Administration was completed

2019

JanuaryThe company was awarded the first batch of top 100 scientific and innovative enterprises of “Three Top 100 Enterprises” by Shanghai Fengxian District Government

AprilThe Second Biogerm Infectious Pathogen Detection Technology Seminar (Shanghai, China)

MayThe company was certified by ICAS ISO 9001/ISO 13485 management system

2018

AprilBiogerm Tarich Virus Target Enrichment Kit for NGS sequencing was launched

JuneThe research and production platform of nucleic acid extraction using magnetic bead method was established
The third generation of virus sequencing technology platform was established

2017

MarchShanghai Biogerm Medical Technology Co., Ltd. was founded

JuneThe research and development platform for pathogen fluorescent PCR kit was launched